Skip to main content
SpringerLink
Log in

Can prostate-specific antigen nadir predict prostate cancer outcomes following radiotherapy?

  • Practice Point
  • Published:

From Nature Clinical Practice Oncology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. American Society for Therapeutic Radiology and Oncology Consensus Panel (1997) Consensus statement: guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 37: 1035–1041

  2. Roach M III et al. (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65: 965–974

    Article  Google Scholar 

  3. Critz FA (2002) A standard definition of disease freedom is needed for prostate cancer: undetectable prostate specific antigen compared with the American Society of Therapeutic Radiology and Oncology consensus definition. J Urol 167: 1310–1313

    Article  Google Scholar 

  4. Lee WR (2005) What variables predict for metastasis in men with biochemical relapse following radiotherapy for prostate cancer? Nat Clin Pract Oncol 2: 340–341

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Sandra Ford, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology,

    W Robert Lee & Judd W Moul

  2. Division of Urology, Duke University School of Medicine, Durham, NC, USA

    W Robert Lee & Judd W Moul

Authors
  1. W Robert Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Judd W Moul
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W Robert Lee.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, W., Moul, J. Can prostate-specific antigen nadir predict prostate cancer outcomes following radiotherapy?. Nat Rev Clin Oncol 3, 534–535 (2006). https://doi.org/10.1038/ncponc0612

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0612

  • Springer Nature Limited

Search

Navigation